Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients

Psychopharmacology

Volumn 210, Issue 3, 2010, Pages 419-428

  Miskowiak, Kamilla W ^a,b   Favaron, Elisa ^b   Hafizi, Sepehr ^b   Inkster, Becky ^c   Goodwin, Guy M ^b   Cowen, Philip J ^b   Harmer, Catherine J ^b  

^a Copenhagen University Hospital ^*  (Denmark)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressant; Depression; Emotion; Neuroimaging; Neuroplasticity

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; CITALOPRAM; ERYTHROPOIETIN; FLUOXETINE; LEVOTHYROXINE; LITHIUM; MIRTAZAPINE; MOCLOBEMIDE; OLANZAPINE; PLACEBO; QUETIAPINE; SERTRALINE; SODIUM CHLORIDE; THYROXINE; TRANYLCYPROMINE; VENLAFAXINE;

ADULT; ALERTNESS; AMYGDALOID NUCLEUS; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; EDUCATIONAL STATUS; EMOTION; FACIAL EXPRESSION; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAPPINESS; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; MALE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; STIMULUS RESPONSE; TEMPORAL CORTEX; VISUAL STIMULATION;

ADULT; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; COGNITION; DEPRESSION; EMOTIONS; ERYTHROPOIETIN; FACIAL EXPRESSION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; PHOTIC STIMULATION; YOUNG ADULT;

EID: 77955566793     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1842-7     Document Type: Article

References (55)

1. Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang MY, Muller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Zhang WQ, Ehrenreich H (2008) Erythropoietin enhances hippocampal long-term potentiation and memory. Bmc Biol 6:37
2. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952:128-134
3. Alcalá-Barraza SR, Lee MS, Hanson LR, McDonald A, Frey WH, McLoon LK (2009) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18:179-190
4. Austin MP, Ross M, Murray C, Ocarroll RE, Ebmeier KP, Goodwin GM (1992) Cognitive function in major depression. J Affect Disord 25:21-29
5. Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
6. Belmaker RH, Agam G (2008) Mechanisms of disease: major depressive disorder. N Engl J Med 358:55-68
7. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151
8. Bhagwagar Z, Cowen PJ, Goodwin GM, Harmer CJ (2004) Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry 161:166-168
9. Bouhuys AL, Geerts E, Gordijn MC (1999) Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study. J Nerv Ment Dis 187:595-602
10. Boynton GM, Engel SA, Glover GH, Heeger DJ (1996) Linear systems analysis of functional magnetic resonance imaging in human V1. J Neurosci 16:4207-4221
11. Bradley BP, Mogg K, Williams R (1995) Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behav Res Ther 33:755-770
12. Brines M, Cerami A (2005) Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6:484-494
13. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A (2000) Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97:10526-10531
14. Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT (2007) Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282:25875-25883
15. DeRubeis RJ, Siegle GJ, Hollon SD (2008) Opinion-cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 9:788-796
16. Desmond JE, Glover GH (2002) Estimating sample size in functional MRI (fMRI) neuroimaging studies: statistical power analyses. J Neurosci Methods 118:115-128
17. Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, Heinz G, Erdag S, Jahn H, Degner D, Ritzen M, Mohr A, Wagner M, Schneider U, Bohn M, Huber M, Czernik A, Pollmacher T, Maier W, Siren AL, Klosterkotter J, Falkai P, Ruther E, Aldenhoff JB, Krampe H (2007a) Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12:206-220
18. Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, Siren AL, Paulus W, Nave KA, Gold R, Bartels C (2007b) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130:2577-2588 (Pubitemid 47511714)
19. Ekman P, Friesen WV (1976) Pictures of facial affect. Consulting Psychologists Press, Palo Alto
20. Ferrario E, Ferrari L, Bidoli P, De CD, Del VM, De DS, Buzzoni R, Bajetta E (2004) Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat Rev 30:563-575
21. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61:877-889
22. Fu CHY, Williams SCR, Brammer MJ, Suckling J, Kim J, Cleare AJ, Walsh ND, Mitterschiffthaler MT, Andrew CM, Pich EM, Bullmore ET (2007) Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry 164:599-607
23. Giacobbe P, Mayberg HS, Lozano AM (2009) Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol 219:44-52
24. Gur RC, Erwin RJ, Gur RE, Zwil AS, Heimberg C, Kraemer HC (1992) Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res 42:241-251
25. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
26. Hamilton JP, Gotlib IH (2008) Neural substrates of increased memory sensitivity for negative stimuli in major depression. Biol Psychiatry 63:1155-1162
27. Hammar A, Lund A, Hugdahl K (2003) Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study. Psychiatry Res 118:189-196
28. Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28:148-152
29. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
30. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59:816-820
31. Harmer CJ, O'Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, Goodwin GM, Cowen PJ (2009a) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166:1178-1184
32. Harmer CJ, Goodwin GM, Cowen PJ (2009b) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195:102-108
33. Kessing LV (1998) Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 28:1027-1038
34. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas ES, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach Atlas labels for functional brain mapping. Hum Brain Mapp 10:120-131
35. Lawrence NS, Williams AM, Surguladze S, Giampietro V, Brammer MJ, Andrew C, Frangou S, Ecker C, Phillips ML (2004) Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55:578-587
36. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA (2002) Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry 51:370-376
37. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233-1239
38. Manji HK, Moore GJ, Rajkowska G, Chen G (2000) Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5:578-593
39. Marcos T, Salamero M, Gutierrez F, Catalan R, Gasto C, Lazaro L (1994) Cognitive dysfunctions in recovered melancholic patients. J Affect Disord 32:133-137
40. Miskowiak K, O'Sullivan U, Harmer CJ (2007) Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action. Biol Psychiatry 62:1244-1250
41. Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2008) Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology 33:611-618
42. Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2009) Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl) 207:133-142
43. Norbury R, Selvaraj S, Taylor MJ, Harmer C, Cowen PJ (2009) Increased neural response to fear in patients recovered from depression: a 3 T functional magnetic resonance imaging study. Psychol Med 40:425-432
44. Rauch SL, Shin LM, Wright CI (2003) Neuroimaging studies of amygdala function in anxiety disorders. Ann N YAcad Sci 985:389-410
45. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001) Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50:651-658
46. Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J 292:344
47. Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA (1982) The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 141:518-523
48. Snyder M, Cantor N (1980) Thinking about ourselves and others-selfmonitoring and social knowledge. J Pers Soc Psychol 39:222-234
49. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, New York
50. Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A, Galli CL, Marinovich M (2005) Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem 93:412-421
51. Vuilleumier P (2005) How brains beware: neural mechanisms of emotional attention. Trends Cogn Sci 9:585-594
52. Vuilleumier P, Pourtois G (2007) Distributed and interactive brain mechanisms during emotion face perception: evidence from functional neuroimaging. Neuropsychologia 45:174-194
53. Williams JMG, Watts FN, MacLeod C, Mathews A (1997) Cognitive psychology and emotional disorders. Wiley, Chichester
54. Woolrich MW, Ripley BD, Brady M, Smith SM (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14:1370-1386
55. Woolrich MW, Behrens TEJ, Beckmann CF, Jenkinson M, Smith SM (2004) Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21:1732-1747